Vaxdyn Readies Vaccines To Target AMR Bacteria

First Spanish Biotech To Get CARB-X Funding

 
• By Sten Stovall
  
Vaxdyn
Researcher-founded Vaxdyn targets infections caused by highly antibiotic resistant bacteria. • Source: Vaxdyn
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Emerging Company Profiles

More from Start-Ups & SMEs